Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Abbott Norge AS
AS
Active
Org 957212158
Rolfsbuktveien 4C, 1364
Fornebu
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1990 · 36 years old
51 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Abbott Norge AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
711M
533M
356M
178M
0M
2020: 391M
391M
2020
2021: 484M (+24% vs 2020)
484M
+24%
2021
2022: 460M (-5% vs 2021)
460M
-5%
2022
2023: 509M (+11% vs 2022)
509M
+11%
2023
2024: 571M (+12% vs 2023)
571M
+12%
2024
EBITDA
NOK millions
60M
45M
30M
15M
0M
2020: 48M
48M
2020
2021: 21M (-56% vs 2020)
21M
-56%
2021
2022: 25M (+19% vs 2021)
25M
+19%
2022
2023: 34M (+36% vs 2022)
34M
+36%
2023
2024: 25M (-26% vs 2023)
25M
-26%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
571 134
508 559
460 489
483 964
391 406
Staff expenses
−86 835
−91 752
−0
−0
−73 119
EBITDA
25 318
34 152
24 544
21 474
48 274
Depreciation & amort.
−3 341
−3 543
−3 693
−3 376
−38 983
EBIT
21 977
30 609
20 852
18 098
9 291
Net financials
5 231
2 768
231
−970
−206
Profit before tax
27 209
33 377
21 082
17 128
9 085
Tax
6 266
7 599
−0
3 911
2 105
Net profit
20 943
25 778
16 139
13 217
6 980
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
284 073
210 169
181 715
160 287
149 080
Equity
132 729
111 787
86 009
69 870
56 653
Long-term debt
514
587
596
424
363
Short-term debt
150 685
97 795
95 110
89 993
92 064
Total debt
151 198
98 382
95 706
90 417
92 427
Financial ratios
5-year trend
EBITDA margin
4,4 %
This company
15,8 %
Market median
This company
Market median
72% below market
2020
2024
Equity ratio
46,7 %
This company
38,2 %
Market median
This company
Market median
22% above market
2020
2024
Return on equity
15,8 %
This company
18,4 %
Market median
This company
Market median
14% below market
2020
2024
Net profit margin
3,7 %
This company
8,1 %
Market median
This company
Market median
54% below market
2020
2024
Asset turnover
2,01×
This company
1,12×
Market median
This company
Market median
79% above market
2020
2024
Debt / equity
1,14×
This company
0,62×
Market median
This company
Market median
84% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Abbott Norge AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
